ANRF funds grants to early career scientists at a time when their ideas are ready for development into research, when support is critical and the unknown could be the path to treatments and cures that change millions of lives.
Since 1970, the ANRF has funded arthritis research to understand the causes, prevention and development of new treatments for osteoarthritis, rheumatoid arthritis, lupus, juvenile arthritis and related autoimmune diseases. The sustainability of the organization is guided by the Board of Directors, the staff and a five-year strategic plan.
As a 501(c)3 nonprofit, the ANRF Board of Directors provides leadership supervision and provides oversight to the organization, assuring financial accountability, policy compliance and assurance strategy is set and goals are met. The ANRF’s Board of Directors is comprised of professionals with different backgrounds and expertise, all who are passionate about the impact of arthritis research.
This is a groundbreaking discovery in the world of autoimmune research and ANRF's history. The research of Gale Granger, Ph.D., who was funded by ANRF, led to a new class of medications, known today as biologics. His work would also transform the way the foundation funded research.
The focus shifted to funding emerging investigators with cutting-edge ideas. like those like Dr. Granger—asking the right questions to find innovative solutions and results that would improve the lives of those living with arthritis and related autoimmune diseases. This new approach to funding research remains the blueprint for how the foundation continues to fund research.
In 1996, the Arthritis National Research Foundation Board of Directors decided to increase arthritis research funding nationwide and hired an executive director to facilitate the expansion. The maximum grant level was $50,000; two grants were awarded in 1996-97, increasing to four by 1998-99.
With the guidance of former grantee, Dr. Granger, a Scientific Advisory Board (SAB) of world-renowned physician-scientists was established to review applications and guide the grant selection process. This SAB established a high level of credibility in the rheumatology and overall medical field, with many original members continuing to serve on the ANRF Board of Directors well into, and beyond, their careers.
Charitable estate planning is financially beneficial for families and individuals of various ages and income levels, and ensures a legacy of commitment to making a difference through funding research, while supporting ANRF’s mission.
19200 Von Karman Ave.
Suite 350
Irvine, CA 92612
800.588.2873
Tax ID #: 95-6043953
